Lung cancer is the most frequently occurring cancer in the world and causes more deaths in the United States than does colon, breast, and prostate cancer combined. Despite advances in treatment modalities including radiation, surgery, and chemotherapy, the overall survival in lung cancer remains low. The cytokine tumor necrosis factor ( TNF ) has been shown to regulate both apoptotic and antiapoptotic pathways. Activation of the transcription factor NF -B appears to be the critical determinant of the antiapoptotic response to TNF exposure in epithelial cells. A549 human lung carcinoma cells were infected with adenoviral constructs carrying dominant negative mutants of Rac1 and IKK or constitutively active mutant of Rac1, upstream effectors in TNF -mediated NF -B activation. Cell death, apoptosis, and NF -B activation were subsequently measured in response to TNF exposure. Although TNF alone had no cytotoxic effect, the expression of the dominant negative mutant of IKK ( Ad.IKKKA ) resulted in apoptotic cell death following TNF exposure. Similarly, dominant negative mutant to Rac1 ( Ad.N17Rac1 ) further sensitized A549 cells to IKKKAmediated TNF -induced cell death. Conversely, a dominant active form of Rac1 ( Ad.V12Rac1 ) ameliorated the cell death response to concurrent IKK dominant negative mutant infection and TNF exposure. These results suggest that concurrent inhibition of Rac1 and IKK pathways sensitizes lung cancer cells to TNF -induced apoptosis. Cancer Gene Therapy ( 2001 ) 8, 897 -905 
A poptosis or programmed cell death is a highly regulated process, which occurs through genetically conserved and complex intracellular pathways. 1 Activation of apoptotic signals leads to chromatin condensation, blebbing of plasma membrane, and DNA fragmentation. 2, 3 The process of apoptosis represents a balance of both stimulatory and inhibitory pathways. Modulating the activity of both apoptotic and antiapoptotic pathways in order to shift the balance toward apoptosis represents an attractive target for cancer therapeutics. 4 Tumor necrosis factor ( TNF) is a pleiotropic cytokine with multiple functions including cell activation, differentiation, and apoptosis. 5 -7 TNF exerts both apoptotic and antiapoptotic effects, which appear to be cell type -defined responses. 8 -11 In some cellular systems, the antiapoptotic effects of TNF appear to be mediated by the up -regulation of NF -B activity. 12, 13 Therefore, antagonism of TNF-mediated NF -B up -regulation represents a unique and potentially useful method to shift the balance of TNF stimulation toward apoptosis and cell death. 14 The interaction of TNF with its receptor ( TNFR1 ) leads to the recruitment of TRADD to the TNF -receptor complex. 15 Activated TRADD interacts with FADD, a caspase 8 activator, leading to the initiation of apoptotic pathways. 16 TRADD also activates and recruits TRAF1, TRAF2, and RIP to the TNFR1 complex. 17 Activated TRAF1 and TRAF2 have been observed in association with the antiapoptotic proteins CIAP1 and CIAP2. Additionally, TRADD activates an antiapoptotic NF -B activity. 13, 18, 19 Therefore, TRADD possesses dual functions: induction of apoptosis through FADD -dependent pathways, and opposition of apoptosis through induction NF -B activity. Prior research using a strategy of selective NF -B down -regulation through the use of proteosome inhibitors enhanced TNF -induced apoptosis in human lung adenocarcinoma cells. 20 Similarly, a stable cell line was generated, expressing a super-repressor form of IB (IBSR ), a strong NF -B inhibitor. 13 This mutant protein prevented NF -B translocation to nucleus and transactivation of gene expression. The expression of the super-repressor form of IB facilitated TNF -induced apoptosis in cells, which were resistant to TNF. 13 Recently, this super-repressor form IB was placed into an adenoviral construct (Ad.IBSR ). Infection of squamous cell lung cancer cells with this vector and subsequent exposure of the cells to TNF induced apoptotic cell death. 21 These studies suggest that preventing the activation of NF -B -dependent gene transcription during TNF stimulation can result in apoptosis.
NF -B is a protein complex composed of two subunits sequestered in the cytoplasm in an inactive state. Upon release of the NF -B subunits from the inhibitory cytoplasmic binding proteins IkB and IkB, it translocates to the nucleus and initiates gene transcription. The protein kinase complex, which initiates NF -B translocation, is termed IB kinase ( IKK ) . IKK is required for the phosphorylation and degradation of IB. 22 -24 It contains two catalytic subunits (IKK, IKK ) and a regulatory subunit (IKK ). 25 -28 It has been previously demonstrated that mice lacking the IB kinase 2 gene ( IKK ) but not IB kinase 1 ( IKK ) exhibited severe liver degeneration, which was dependent on TNF signaling. 29, 30 More specifically, the IKK subunit has been shown to be essential for NF -B activation and protection from apoptosis in vivo. 31 We have generated an adenoviral construct expressing a dominant negative mutant of IKK ( Ad.IKKKA ) to investigate the potential of this adenoviral construct to inhibit NF -B activation and promote TNF -mediated cell death. Additionally, we have employed two other adenovirus vectors containing Rac1 mutants to examine the effect of Rac1 signaling on TNF -mediated cytotoxicity. These vectors have been tested alone and /or in combination to determine if simultaneous inhibition of distinct NF -B activation pathways enhances TNF -mediated apoptosis in lung cancer cells.
MATERIALS AND METHODS

Generation of gene transfer vectors
Seven recombinant adenoviral vectors expressing either -galactosidase ( Ad.LacZ ), 32 enhanced green fluorescent protein ( Ad.EGFP ) (Vector Core, University of Iowa, Iowa City, IA ) , a dominant negative mutant of Rac1 ( Ad.N17-Rac1), 33 a dominant active mutant of Rac1 ( Ad.V12-Rac1) , 34 a dominant negative mutant form ( K44M ) of IKK ( Ad.IKKKM ) , a dominant negative mutant form ( K44A ) of IKK (Ad.IKKKA ), or a Luciferase reporter gene driven by NF -B transcriptional activation ( Ad.NFBLuc ) were used for functional studies. Ad.IKKKM and Ad.IKKKA were constructed from pRc -actin plasmids encoding either the dominant negative mutant of IKK ( IKKKM ) or IKK ( IKKKA ). 35 Fragments encoding the HA -tagged IKKKM or IKKKA cDNA were excised by HindIII -NotI restriction digestion from pRc -actin plasmids and blunt -subcloned into EcoRV site of the pAd.CMV-Link1 adenoviral shuttle plasmid. Recombinant adenoviruses were generated in 293 cells according to a procedure established by Anderson et al. 36 The expression of HA -IKKKM or HA -IKKKA from adenoviral constructs was confirmed by Western blotting. pNF -B -Luc plasmid (Clontech Laboratories, Palo Alto, CA ) was used to produce Ad.NF -BLuc vector. The DNA, encoding the Luciferase gene driven by four tandem copies of the NFB consensus sequence attached to a TATA -like promoter from the herpes simplex virus thymidine kinase gene was cleaved by KpnI and XbaI double digestion. The KpnI and XbaI fragment was inserted into a promoterless Adenoviral shuttle plasmid ( pAd5mcspA ) 36 and Ad.NF -BLuc virus was produced by homologous recombination. Recombinant adenoviral stocks were generated as previously described, 37 and were stored in 10 mM Tris with 20% glycerol at À 808C. The particle titers of adenoviral stocks were determined by A 260 readings and were typically 10 13 DNA particles /mL. The functional titers of adenoviral stocks were assessed by plaque titering on 293 cells and expression assays for encoded proteins. Typically, the particle /pfu ratio was equal to 50.
Adenovirus transduction assays
A549 cells were infected with Ad.EGFP virus at increasing MOIs at 378C in DMEM without FBS. Two hours following infection, the serum concentration in the tissue culture media was increased to 10% by adding equal volumes of DMEM supplemented with 20% fetal bovine serum. The percent GFP ( + ) cells was determined at 48 hours by fluorescent microscopy. Infected cells were maintained by providing fresh media twice a week; the longevity of infection was determined by examining cells under fluorescent microscopy for about 6 weeks following initial infection.
Luciferase assays
The Luciferase Assay System with Reporter Lysis Buffer ( catalog no. E4030; Promega, Madison, WI ) was used to assess NF -B -induced transcriptional activation according to the manufacturer's instructions. All measurements of Luciferase activity ( relative light units ) were normalized to the protein concentration of harvested cell lysates. The NF -B responsive Luciferase reporter vector, Ad.NFBluc, was used to coinfect cells at an MOI of 5000 particles /cell in these experiments.
TNF treatments and live / dead cellular viability assays rhTNF (catalog no.210 -TA ) was obtained from R&D Systems (Minneapolis, MN ) . Forty -eight hours after infection with the adenovirus vectors, A549 cells were exposed to recombinant human TNF (rhTNF ) at 100 ng /mL for an additional 7 or 24 hours. Molecular Probes' (Eugene, OR ) LIVE / DEAD Viability /Cytotoxicity Kit for animal cells (L -3224) was used to distinguish live cells from the dead after various treatments. Calsein AM, a fluorogenic substrate for intracellular calsein esterase, is converted to a green fluorescent product (calsein ), which is detectable only in live cells. Because only live cells with intact membranes contain active calsein esterase, detection of calsein by fluorescent microscopy functions as a marker for viable cells. Ethidium homodimer-1 (EthD -1 ) is a red fluorescent nucleic acid stain, which cannot diffuse across intact cell membranes. Cells with damaged membrane integrity stain positive with EthD -1, whereas intact cells exclude the stain.
Caspase activity assays
CaspaTag Caspase Activity Kits were used to selectively assess caspase activation following infection and exposure to hTNF. In these assays, carboxyfluorescein -labeled, caspase inhibitors irreversibly bind to active caspases. The caspase inhibitor substrates were designed to be specific for both the active state of the enzyme and a specific isoform. Caspase ( + ) cells were distinguished from caspase ( À ) cells by fluorescence microscopy. FAM -DEVD -FMK inhibitor (S7301 ) was used for caspase 3 activation assay. FAM -LETD -FMK inhibitor (S7304 ) was used for caspase 8 activation assay.
RESULTS
A549 cells are susceptible to infection with adenoviral vectors
Adenovirus transduction of normal lung has shown to be only moderately effective in mice, rats, primates, and humans. 38 -43 However, transduction of A549 cells, a line of lung cancer cells, has been shown to be effective using adenovirus vector systems. 44 Therefore, we have selected this human lung carcinoma cell line, A549, to test our hypothesis that TNF exposure can provoke a modulated apoptotic response in the setting of differential NF -B inhibition. To establish the efficacy of infection using firstgeneration adenovirus constructs in our laboratory, A549 cells were infected with an adenovirus encoding enhanced green fluorescein protein (Ad.EGFP ). The level of viral transduction indicated as the percentage of cells with GFP expression was determined at various time points after the infection (Fig 1 ) . By 48 hours, more than 90% of the cells was transduced with Ad.EGFP virus at MOI of 5000 DNA particles /cell ( Fig 1B ) . The transduction appeared to be stable in nonproliferating, confluent cell culture conditions, and the percent transduction did not show significant attenuation when measurements were repeated 6 weeks following initial infection ( data not shown) . Additionally, no obvious cytotoxic effect or loss of cell viability was 
IKKKA mutant expression suppressed TNF -induced NF -B activation
Prior research has established that TNF activates both apoptotic and antiapoptotic pathways in epithelial cells. 10, 14, 45 The specific cellular response to TNF stimulation may depend on the subsequent activity of NF -B. In order to block potential antiapoptotic activity of the NF -B pathway, a recombinant adenovirus construct expressing the dominant negative mutant of IKK ( Ad.IKKKA ) was generated. The functional consequence of infection with this adenovirus construct on NF -B activity was tested using a NF -B Luciferase reporter assay system. A549 cells were coinfected with separate adenoviruses encoding both the NF -B -driven Luciferase reporter gene and the dominant negative IKK. Infection of A549 cells with Ad.IKKKA, but not Ad.LacZ control, resulted in a dose -dependent decrease in TNF -stimulated NF -B activity (Fig 2) .
Ad.IKKKA infection sensitized lung cancer cells to hTNF -induced cell death A549 cells were infected with Ad.IKKKA virus prior to treatment with hTNF to determine the effects NF -B inhibition on cell survival. As seen in Figure 3 , Ad.IKKKA infection followed by hTNF treatment significantly decreased cell viability in a dose -dependent manner. Although first -generation adenovirus vectors themselves have been shown to induce apoptosis, 46 control experiments using only Ad.LacZ virus at the same MOI dose did not produce cytotoxicity in combination with hTNF as measured by calsein activity ( Fig 3 ) . These results suggest that IKK plays a critical role in mediating the balance of death or survival signaling by TNF in A549 cells.
Ad.IKKKA infection followed by hTNF treatment activates caspase pathways
Caspase activation has previously been shown to correlate with initiation of apoptotic cell death. Caspase activity assays were performed in A549 cells infected with Ad.IKKKA virus for 48 hours followed by 7 hours of hTNF treatment to further define the mechanisms underlying the observed increase in cytotoxic effect. Both caspase 8 ( Fig 4A ) and caspase 3 (Fig 4B ) demonstrated increased activity in cells infected with Ad.IKKKA virus following hTNF treatment. These results suggest that hTNF activated unopposed proapoptosis pathways during concurrent NF -B inhibition by the dominant negative IKK.
Constitutively active Rac1 protects A549 cells from IKKKA -induced and TNF -mediated ( IKKKA -TNF ) apoptosis
Recently, a constitutively active form of the small GTPase protein Rac1 ( V12Rac1) has been shown to up -regulate NF -B activity in HeLa cells. 34 Expression of a dominant negative Rac1 (N17Rac1 ) has been shown to both directly inhibit NF -B activity and to sensitize cells to TNFmediated apoptosis. 34, 47 Both the dominant active form of Rac1 (Ad.V12Rac1 ) and the dominant negative form ( Ad.N17Rac1 ) were tested to evaluate their effects on TNF responsiveness in A549 cells. As indicated in Figure  5A , only the infection of A549 cells with Ad.N17Rac1 virus, but not with Ad.V12Rac1, produced cell death and loss of viability in response to hTNF treatment. Maximum cell death ( 55% ) was observed with MOI of 10,000 DNA particles / cell of Ad.N17Rac1; no further increase in cell death was detected when the MOI was doubled to 20,000 DNA particles /cell. In the absence of hTNF treatment, no significant degree of cell loss was observed with either of these two mutants (data not shown) .
In additional experiments, A549 cells were also coinfected with Ad.IKKKA and either the constitutively active or dominant negative forms of Rac1 to determine the effect of Ad.NFκBLuc (MOI) 5000 5000 5000 5000 5000 5000 5000 5000 TNF (ng/ml) 0 100 100 100 100 100 100 100 Ad. simultaneous inhibition of these two converging pathways on TNF responsiveness. As shown in Figure 5B , 90% of cell death was observed with Ad.IKKKA infection alone at an MOI of 5000 DNA particles /cell followed by hTNF treatment. When cells were coinfected with Ad.V12Rac1 virus carrying constitutively active Rac1 mutant, a dosedependent decrease in cytotoxicity was observed (Fig 5B ) . These observations suggest that V12Rac1 overrides the apoptotic signaling induced by TNF in the setting of IKK inhibition.
N17Rac1 potentiates IKKKA -induced IKKKA -induced TNF -mediated cytotoxicity in A549 cells
Given the beneficial effect of V12Rac1 on cell survival following hTNF exposure, experiments were conducted to determine the effect of a dominant negative Rac1 on cell death. As seen in Figure 5C , Ad.IKKKA infection at an MOI of 1000 DNA particles / cell alone combined with TNF treatment resulted in approximately 30% cell death. Coinfection of these cells with Ad.N17Rac1 virus produced a dose -dependent increase in the degree of cell death ( Fig 5C ) . These results suggest that combined use of Ad.IKKKA and Ad.N17Rac1 to inhibit two different aspects of a converging pathway represents an attractive target for potentially therapeutic interventions.
V12Rac1 rescue and N17Rac1 sensitization of IKKKA TNF -induced apoptosis is mediated through NF -B
In order to determine the effect of V12Rac1 on NF -B activity during concurrent Ad.IKKKA infection and TNF stimulation, NF -B activity assays were performed. As seen in Figure 6A , hTNF -induced NF -B activation was abolished with Ad.IKKKA infection of A549 cells. Coinfection of these cells with Ad.V12Rac1 ameliorated IKKKA suppression of hTNF -induced NF -B activation. This partial restoration of NF -B activity demonstrated a dose dependence on the concentration of Ad.V12Rac1. On the contrary, Ad.N17Rac1 infection further decreased NF -B activity compared to Ad.IKKKA infection alone ( Fig 6B ) . This effect of N17Rac1 also correlated well with the extent of cell death, as demonstrated in Figure 5C . Furthermore, Ad.IKKKA infection down -regulated V12Rac1 -induced NF -B activation in a dose -dependent fashion (Fig 6C ) . No down -regulation of NF -B activity was evident with Ad.LacZ virus. This suggests that IKK subunit plays a functional role in the transmission of signal from Rac1 to NF -B. Although experiments with a dominant negative subunit of IKK delivered through the vector, Ad.IKKKM, demonstrated an inhibition of NF -B activity, the degree was significantly less than dominant negative IKK (Fig 6D ) . This functional difference did not appear to be related to differential levels of protein represent the mean of ( ± SEM ) of four independent data points.
Cancer Gene Therapy, Vol 8, No 11, 2001 expression based on Western blotting for HA -tagged IKKKM and IKKKA (data not shown) . In summary, these results suggest that NF -B activity can be decreased in a dose -dependent manner by infection with adenovirus vectors containing dominant negative IKK and Rac1 mutants.
DISCUSSION
Previous studies examining gene therapy for inherited diseases such as cystic fibrosis have reported difficulty in achieving efficient and sustained adenoviral transduction of normal lung cells. 39, 40, 42, 43, 48, 49 The low efficiency of adenovirus -mediated gene transfer to fully differentiated and polarized airway epithelial cells has been attributed to low -level expression of the coxsackie /adenovirus receptor ( CAR ) 50, 51 on the apical surface of airway epithelial cells. 52 -54 Consequently, cells with low CAR expression are difficult targets for adenovirus -mediated gene transfer. 55 On the contrary, the A549 human airway epithelial cell line has been demonstrated to express high levels of CAR receptor. 44 Therefore, we have chosen this cancer cell line to test if this particular type of lung cancer cell line can be sensitized to TNF-induced apoptosis by modulating IKK and Rac1 signaling pathways.
Our initial experiments with adenovirus containing the gene for a marker protein, EGFP, confirmed that the human lung cancer cell line, A549, could be efficiently transduced with a first -generation recombinant adenovirus vector. Although a direct apoptotic effect of the vector itself has been previously demonstrated in lung cancer cell lines, 46 we observed no direct toxic effect of first generation recombinant adenovirus vectors carrying LacZ or EGFP reporter genes in A549 cells.
Previous authors have stated that gene therapy designed to subvert normal cell signaling pathways including apoptosis could be a potentially useful therapeutic approach to cancer. 4, 13 A particularly attractive target for this therapeutic approach has been TNF -induced apoptosis. Although TNF alone may have direct apoptotic effects, 9, 11, 56 many studies have documented that the balance of TNF effects is shifted toward apoptosis only in the setting of concurrent blockade of NF -B.
12,14 In tumor cell lines, TNF -mediated apoptosis has been shown to occur in the setting of NF -B 13,21 inhibition. Because NF -B activation is dependent on multiple converging pathways, including activation of IB kinase, 57 phosphorylation of subunit transactivation domains, 58, 59 and association with basal transcription factors, 60, 61 an approach based on simultaneous inhibition of parallel pathways could more effectively inhibit NF -B activity. Both Rac1 and IKK have been established as signal transduction proteins in NF -B activation. Furthermore, Rac1 has been previously demonstrated to possess NF -B activating function, which is independent of IkB protein degradation. 62 Given the observation that Rac1 inhibition by itself can augment TNF -mediated apoptosis, 47 we studied the combined effects of IKK inhibition and Rac1 inhibition on TNF -mediated apoptosis.
Our results indicate that IKKKA expression sensitized A549 cells to TNF-induced apoptosis. The results from these experiments show that antiapoptotic signaling can be inhibited through upstream blockade of NF -B activation. Caspase activity assays specifically confirmed the activation of apoptotic pathways during concurrent NF -B inhibition and TNF exposure. Thus, the susceptibility to TNF-induced apoptosis appears to be somewhat dependent on IKK activity. Although both IKK and IKK mutants inhibited V12Rac1 -mediated NF -B up -regulation ( Fig 6C and D ) , the IKK appeared more potent. Considering the fact that similar levels of protein expression from Ad.IKKKM and Ad.IKKKA constructs were detected in A549 cells by Western blotting ( data not shown) , this effect could not be attributed to differential protein expression. These observations correlate with other experiments in which an IKK knockout mouse mutant, 30 but not IKK, 29 exhibited severe liver degeneration due to TNF.
Reprogramming A549 cells through the expression of a dominant active form of Rac1 ( V12Rac1) was able to block apoptotic activation by IKKKA expression combined with TNF treatment. One potential explanation for these results is that despite IKKKA expression, functional IKK subunit was able to transmit V12Rac1 -induced signaling to NF -B (Fig 6D ) , thus permitting its transactivation. Conversely, the negative mutant to Rac1 ( N17Rac1) further sensitized A549 cells to IKKKAmediated, TNF-induced apoptosis. From these results, it appears that IKKKA and N17Rac1 constructs could be used in combination to facilitate TNF-induced cell killing of lung cancer cells. The molecular mechanism of IKK activity modulation by Rac1 remains unclear; however, it is possible that this putative pathway could also form an attractive target for gene therapy as well.
One of the main obstacles of cancer gene therapy is to be able to specifically target cancer cells. Although our research does not directly address issues regarding specific tumor cell targeting by adenoviral vectors, a number of recent reports and discussions have proposed methods to alter the tropism of adenovirus vectors. The possible targets for creating specific vector cell targeting have included the insertion of RGD peptides into adenoviral fiber proteins to target the integrin recognition sites on ovarian cancer cells 63 and rhabdomyosarcoma cells. 64 In addition, a bispecific antibody linking fiber protein to epidermal growth factor receptor was used to target glioma cells. 65, 66 By taking advantage of the observation that fibroblast growth factor receptors appear to be overexpressed in some malignant cells, Kaposi's sarcoma cells have been successfully targeted by adenoviral constructs using antiknob Fab fragment linked to FGF. 67 Identification of specific lung cancer cell markers could potentially serve as the basis for the development of similar specific targeting techniques for lung cancer cells.
Our results not only demonstrate the sensitization of A549 cells to TNF-induced apoptosis by two pathways, but also describe a novel application in which combinatorial use of Ad.N17Rac1 and Ad.IKKKA has been demonstrated to be more effective than their individual administrations. Therefore, we have shown that adenovirus vectors are capable of 
